For the Inventor, By the Inventor

Enter assignee name

Burlingame, CA, United States of America

Valentis, Inc.

USPTO Granted Patents = 11

% Expired Patents = 18.2

Forward Citations = 316

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Cori M Gorman (2 out of 3 patents)

Ross Durland (1 out of 3 patents)

Jinkang Wang (1 out of 10 patents)

4. Warren Dang (1 out of 3 patents)

5. Lee B Bussey (1 out of 7 patents)

6. Audrey Yu-Speight (1 out of 2 patents)

7. John Welp (1 out of 2 patents)

8. Rexford Hayes (1 out of 2 patents)

9. Kwok-Leung (Jacky) Au-Yeung (1 out of 3 patents)

10. Alain Rolland (1 out of 6 patents)

11. Thomas Quertermous (1 out of 6 patents)

12. Thomas Joel Zupancic (1 out of 17 patents)

13. Kuoewi Wu (1 out of 1 patent)

14. Robert Harlan Bridenbaugh (1 out of 4 patents)

15. Maria Bruno (1 out of 2 patents)

11 patents: Sort by Forward Citations

1. 7314746 - Apparatus and method for preparative scale purification of nucleic acids (2008-01-01),

2. 7041801 - Antibodies binding to polypeptides encoded by developmentally-regulated endothelial cell locus-1 (2006-05-09),

3. 7026468 - Process and equipment for plasmid purification (2006-04-11),

4. 6534483 - Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods (2003-03-18),

5. 6514947 - Formulated nucleic acid compositions and methods of administering the same for gene therapy (2003-02-04),

6. 6344446 - Cationic lipid:DNA complexes for gene targeting (2002-02-05),

7. 6303378 - Methods for preparing polynucleotide transfection complexes (2001-10-16),

8. 6271209 - Cationic lipid formulation delivering nucleic acid to peritoneal tumors (2001-08-07),

9. 6271206 - Sonic nebulized nucleic acid/cationic liposome complexes and methods for pulmonary gene delivery (2001-08-07),

10. 6235310 - Methods of delivery using cationic lipids and helper lipids (2001-05-22),

11. 5932241 - Cationic lipid DNA complexes for gene targeting (1999-08-03),

Company Overview

Valentis, Inc. is a biotechnology company based in Burlingame, California, focused on developing innovative therapeutic solutions. The company specializes in advanced drug delivery systems and novel therapeutic modalities, particularly in the fields of oncology and immunology. Valentis leverages its proprietary technologies to enhance the efficacy and safety of treatments, aiming to address unmet medical needs through cutting-edge research and development. Its commitment to scientific excellence positions it as a key player in the biopharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

11 Patents

#19 in Burlingame, CA

#6,532 in California

#27,490 in US

#51,714 in the World

Burlingame, CA, United States of America

Valentis, Inc.

Forward Citations = 316

31 inventors:

Cori M Gorman (2 out of 3 patents)

Ross Durland (1 out of 3 patents)

Jinkang Wang (1 out of 10 patents)

4. Warren Dang (1 out of 3 patents)

5. Lee B Bussey (1 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Valentis, Inc.. Retrieved from https://idiyas.com/company/valentis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…